Epidemiology of rosacea

Потекаев, Н. Н.; Хамаганова, И. В.; Новожилова, О. Л.; Lebedeva, G. A.

doi:10.17116/klinderma20161514-7

Cited by 3 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to the concept of "psychodermatology", rosacea belongs to a group of pathologies with predominance of psychosomatic disorders as a result of the personality's reaction to a chronic recurrent disease (Šitum et al 2016;Sharshunova et al 2017). The development of mental and vegetative changes, therapy resistance, and communicating discomfort limit social contacts and significantly affects the quality of patients' life.…”

Section: Introductionmentioning

confidence: 99%

Psychophysiological parameters in rosacea patients after complex therapy with Cortexin

Bobrakova¹

2020

RRP

View full text Add to dashboard Cite

Introduction: Taking into account the influence of the psycho-emotional sphere and its disorders on the pathogenetic mechanisms of rosacea, a comparative assessment of the clinical efficacy of a standard therapy and the complex therapy using Cortexin in papulopustular rosacea patients with moderate severity and concomitant neurological pathology was performed. The therapy influence on changes in the patients’ psycho-emotional state was also studied. Materials and methods: The study involved 216 papulopustular rosacea outpatients with moderate severity with a concomitant neurological pathology, aged 20 to 60 years. The patients were divided into 2 groups: 109 people (37 men and 72 women) in the study group, and 107 people (37 men and 70 women) in the control. All the patients received a treatment according to the ”Standard of Medical Care for Patients with Rosacea” of the Ministry of Health of the Russian Federation. The study group patients additionally received Cortexin. The study was carried out using the Zung Self-Rating Anxiety Scale (SAS), the Taylor Manifest Anxiety Scale, the Spielberger State-Trait Anxiety Inventory, and the Eysenck Personality Questionnaire. Results and discussion: The patients showed an increase in somatic manifestations of anxiety, levels of trait and state anxiety, and neuroticism initially before the start of treatment. The inclusion of Cortexin in the rosacea treatment reduced the somatic manifestations of anxiety more effectively than standard therapy against the background of a more considerable decrease in proportion of patients with its moderate and high levels. The severity of trait and stateanxiety, neuroticism was also significantly lower against the background of the Cortexin use than with the standard treatment. Conclusion: The Cortexin inclusion in the rosacea pharmacotherapy against the background of a concomitant neurological pathology contributes to a more pronounced correction of psychophysiological parameters, reflecting the neuroticism levels, trait and state anxiety, and somatic manifestations of anxiety, compared to standard treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Psychophysiological parameters in rosacea patients after complex therapy with Cortexin

Bobrakova¹

2020

RRP

View full text Add to dashboard Cite

show abstract

First experience of using ivermectin and brimonidine tartrate in patients with rosacea: case studies

Потекаев¹,

Lvov²,

Khlystova³

et al. 2017

Klin. dermatol. venerol.

Self Cite

View full text Add to dashboard Cite

Розацеа (acne rosacea, gutta rosacea, erythrosis facialis, сuperosis)-хроническое, рецидивирующее заболевание, как правило, кожи лица, имеющее полиэтиологическую природу и характеризующееся стадийным течением [1]. Заболеваемость розацеа в общей структуре дерматозов в разных странах колеблется от 1 до 22%, причем эти показатели наиболее высоки в Австралии, Северной Европе и США. По данным современных клинико-эпидемиологических исследований [3, 4], заболеваемость розацеа в России много лет остается стабильной, и на 2016 г. составляет около 5%. Известно, что дерматоз чаще встречается у женщин (до 75%), преимущественно у людей с I-II фототипом кожи, средний возраст проявления данной патологии приходится в среднем на 30-50 лет. Эпидемиологические данные, однако, не полным образом раскрывают истинную распространенность заболевания. По-видимому, многие пациенты не обращаются за квалифицированной медицинской помощью или наблюдаются в клиниках косметологического профиля [2-4].

show abstract

Combined rosacea treatment protocol using a pulsed dye laser and a dermal bioreparant with trehalose

Chebotareva,

Tonakanyan,

Privalova

2023

Klin. dermatol. venerol.

View full text Add to dashboard Cite

Epidemiology of rosacea

Cited by 3 publications

References 18 publications

Psychophysiological parameters in rosacea patients after complex therapy with Cortexin

Psychophysiological parameters in rosacea patients after complex therapy with Cortexin

First experience of using ivermectin and brimonidine tartrate in patients with rosacea: case studies

Combined rosacea treatment protocol using a pulsed dye laser and a dermal bioreparant with trehalose

Contact Info

Product

Resources

About